WallStreetZenWallStreetZen

NASDAQ: AFIB
Acutus Medical Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for AFIB

Based on 3 analysts offering 12 month price targets for Acutus Medical Inc.
Min Forecast
$1.50+72.02%
Avg Forecast
$2.00+129.36%
Max Forecast
$3.00+244.04%

Should I buy or sell AFIB stock?

Based on 4 analysts offering ratings for Acutus Medical Inc.
Hold
Strong Buy
1 analysts 25%
Buy
0 analysts 0%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their AFIB stock forecasts and price targets.

AFIB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Top 20%
81
HoldMaintains$1.50+72.02%2022-08-16
BTIG
Top 8%
93
Strong BuyMaintains$1.50+72.02%2022-06-24
Anonymous
Goldman Sachs
HoldMaintains$1.00+14.68%2022-04-14
Canaccord Genuity
Bottom 13%
13
HoldDowngrades$3.00+244.04%2022-01-14
JP Morgan
Top 15%
86
Strong SellDowngradesN/AN/A2021-11-12

1 of 1

Forecast return on equity

Is AFIB forecast to generate an efficient return?
Company
N/A
Industry
19.64%
Market
108.79%

Forecast return on assets

Is AFIB forecast to generate an efficient return on assets?
Company
N/A
Industry
10.86%

AFIB earnings per share forecast

What is AFIB's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$2.84
Avg 2 year Forecast
-$2.77

AFIB revenue forecast

What is AFIB's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$16.2M-3.08%
Avg 2 year Forecast
$19.6M+17.43%
Avg 3 year Forecast
$30.9M+84.51%
AFIB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AFIB revenue growth forecast

How is AFIB forecast to perform vs Medical Devices companies and vs the US market?
Company
14.34%
Industry
4.48%
Market
8.22%
AFIB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AFIB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AFIB vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AFIB$0.87$2.00+129.36%Hold
SRGA$3.41$1.50-56.01%Hold
VERO$0.43$5.50+1,191.08%Strong Buy
DCTH$3.27$19.50+496.33%Strong Buy
SSKN$0.84$4.30+411.90%Strong Buy

Acutus Medical Stock Forecast FAQ

Is Acutus Medical Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: AFIB) stock is to Hold AFIB stock.

Out of 4 analysts, 1 (25%) are recommending AFIB as a Strong Buy, 0 (0%) are recommending AFIB as a Buy, 2 (50%) are recommending AFIB as a Hold, 0 (0%) are recommending AFIB as a Sell, and 1 (25%) are recommending AFIB as a Strong Sell.

If you're new to stock investing, here's how to buy Acutus Medical stock.

What is AFIB's earnings growth forecast for 2022-2023?

(NASDAQ: AFIB) Acutus Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.15%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.27%.

Acutus Medical's earnings in 2022 is -$94,074,000.On average, 1 Wall Street analyst forecast AFIB's earnings for 2022 to be -$80,571,783, with the lowest AFIB earnings forecast at -$80,571,783, and the highest AFIB earnings forecast at -$80,571,783.

In 2023, AFIB is forecast to generate -$78,585,858 in earnings, with the lowest earnings forecast at -$78,585,858 and the highest earnings forecast at -$78,585,858.

What is AFIB's revenue growth forecast for 2022-2024?

(NASDAQ: AFIB) Acutus Medical's forecast annual revenue growth rate of 14.34% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.48%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.22%.

Acutus Medical's revenue in 2022 is $16,720,000.On average, 2 Wall Street analysts forecast AFIB's revenue for 2022 to be $459,741,457, with the lowest AFIB revenue forecast at $459,599,605, and the highest AFIB revenue forecast at $459,883,309. On average, 2 Wall Street analysts forecast AFIB's revenue for 2023 to be $557,051,744, with the lowest AFIB revenue forecast at $553,221,747, and the highest AFIB revenue forecast at $560,881,740.

In 2024, AFIB is forecast to generate $875,225,174 in revenue, with the lowest revenue forecast at $875,225,174 and the highest revenue forecast at $875,225,174.

What is AFIB's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: AFIB) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.86%.

What is AFIB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AFIB price target, the average AFIB price target is $2.00, with the highest AFIB stock price forecast at $3.00 and the lowest AFIB stock price forecast at $1.50.

On average, Wall Street analysts predict that Acutus Medical's share price could reach $2.00 by Aug 16, 2023. The average Acutus Medical stock price prediction forecasts a potential upside of 129.36% from the current AFIB share price of $0.87.

What is AFIB's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: AFIB) Acutus Medical's current Earnings Per Share (EPS) is -$3.32. On average, analysts forecast that AFIB's EPS will be -$2.84 for 2022, with the lowest EPS forecast at -$2.84, and the highest EPS forecast at -$2.84. In 2023, AFIB's EPS is forecast to hit -$2.77 (min: -$2.77, max: -$2.77).

What is AFIB's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: AFIB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.